| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 176131 |
CAS:129618-40-2 Nevirapine 奈韦拉平 批量合成 |
325 |
zcy |
2024-04-03 |
| 176132 |
CAS:135159-51-2 Sarpogrelate (hydrochloride) 盐酸沙格雷酯 批量合成 |
305 |
zcy |
2024-04-03 |
| 176133 |
CAS:10402-53-6 Eprazinone (dihydrochloride) 盐酸依普拉酮 原研药中间体供应 |
296 |
kx |
2024-04-03 |
| 176134 |
Poly(vinyl phosphonate)sodium salt,PVPhos,聚乙烯基膦酸酯钠 |
320 |
h |
2024-04-03 |
| 176135 |
CAS:1004316-88-4 Cobicistat 可比司他 新药中间体工艺 |
324 |
zcy |
2024-04-03 |
| 176136 |
CAS:3166-62-9 Methylbenactyzium Bromide 溴甲乙胺痉平 药物分子开发 |
208 |
kx |
2024-04-03 |
| 176137 |
mPEG-P(D)La,甲氧基-聚乙二醇-聚D-丙交酯 |
248 |
h |
2024-04-03 |
| 176138 |
mPEG-b-PLGA,甲氧基聚乙二醇-b-聚(D,L-丙交酯-co-乙交酯) |
402 |
h |
2024-04-03 |
| 176139 |
CAS:1009119-64-5 Daclatasvir 达卡他韦 药物分子开发 |
337 |
zcy |
2024-04-03 |
| 176140 |
CAS:8047-67-4 Iron sucrose 蔗糖铁 原料药研发 |
335 |
kx |
2024-04-03 |
| 176141 |
5,10,15,20-四[4-(2-甲基-1H-咪唑基)苯基] -21H,23H-卟吩,定制服务 |
252 |
axc |
2024-04-03 |
| 176142 |
Methoxy poly(ethylene glycol)-poly(5-benzyloxy-trimethylene carbonate) |
231 |
h |
2024-04-03 |
| 176143 |
CAS:1009119-65-6 Daclatasvir (dihydrochloride) 达卡他韦二盐酸盐 药物分子开发 |
346 |
zcy |
2024-04-03 |
| 176144 |
CAS:213997-73-0 Norvancomycin (hydrochloride) 盐酸去甲万古霉素 批量合成 |
249 |
kx |
2024-04-03 |
| 176145 |
CAS:1072833-77-2 Ixazomib 艾沙佐米 新药中间体KG级 |
235 |
zcy |
2024-04-03 |
| 176146 |
CAS:61477-96-1 Piperacillin 哌拉西林 工艺优化 |
283 |
kx |
2024-04-03 |
| 176147 |
CAS:842133-18-0 Canagliflozin 卡格列净 新药中间体工艺 |
259 |
zcy |
2024-04-03 |
| 176148 |
CAS:16846-24-5 Josamycin 交沙霉素 化合物合成 |
219 |
kx |
2024-04-03 |
| 176149 |
CAS:960404-48-2 Dapagliflozin ((2S)-1,2-propanediol, hydrate) 达格列净一水丙二醇 原研药中间体供应 |
391 |
zcy |
2024-04-03 |
| 176150 |
2HTCNPP,14609-51-9,5,10,15,20-四(4-氰基苯基)卟啉,四氰基苯基卟啉 |
310 |
axc |
2024-04-03 |
| 176151 |
CAS:24916-51-6 Acetylspiramycin 乙酰螺旋霉素 路线研究 |
225 |
kx |
2024-04-03 |
| 176152 |
CAS:461432-26-8 Dapagliflozin 达格列净 药物分子开发 |
439 |
zcy |
2024-04-03 |
| 176153 |
mPEG-P(5BZTMC),聚乙二醇-聚(5-苄氧基-三亚甲基碳酸酯) 两亲性二嵌段共聚物 |
383 |
h |
2024-04-03 |
| 176154 |
CAS:52093-21-7 Micronomicin 小诺霉素 中试供应 |
214 |
kx |
2024-04-03 |
| 176155 |
Poly(ethylene glycol)-b-poly(D,L-lactic acid)-decyl,聚乙二醇-聚DL-乳酸-癸基 |
248 |
h |
2024-04-03 |
| 176156 |
cas14609-51-9,5,10,15,20-四(4-氰基苯基)卟啉,Meso-Tetra(4-cyanobenzyl)porphine |
279 |
axc |
2024-04-03 |
| 176157 |
PEG-PDLLA-Decyl,聚乙二醇-聚DL-乳酸-癸基 |
268 |
h |
2024-04-03 |
| 176158 |
CAS:404-86-4 Capsaicin 辣椒碱 新药中间体放大 |
230 |
zcy |
2024-04-03 |
| 176159 |
CAS:35457-80-8 Midecamycin 麦迪霉素 小试供应 |
321 |
kx |
2024-04-03 |
| 176160 |
间-四(对 - 溴苯基)卟啉,cas29162-73-0,meso-Tetra (p-bromophenyl) porphine,5,10,15,20-四(4-溴苯基)卟啉 |
300 |
axc |
2024-04-03 |
| 176161 |
Poly(DL-Lactide)-b-Poly(ethylene glycol)-Maleimide,聚乳酸聚乙二醇马来酰亚胺 |
249 |
h |
2024-04-03 |
| 176162 |
CAS:146464-95-1 Pralatrexate 普拉曲沙 新药中间体中试 |
258 |
zcy |
2024-04-03 |
| 176163 |
CAS:14897-39-3 Rifamycin (sodium) 利福霉素钠盐 公斤级 |
304 |
kx |
2024-04-03 |
| 176164 |
PLA-PEG-Mal,聚乳酸聚乙二醇马来酰亚胺 |
251 |
h |
2024-04-03 |
| 176165 |
CAS:1809249-37-3 Remdesivir 瑞德西韦 原研药中间体供应 |
250 |
zcy |
2024-04-03 |
| 176166 |
cas160240-15-3,5,10,15,20-四(4-乙炔基苯基)卟啉,分子量:710.821 |
258 |
axc |
2024-04-03 |
| 176167 |
CAS:56839-43-1 Eperisone (hydrochloride) 盐酸乙哌立松 化合物优化 |
306 |
kx |
2024-04-03 |
| 176168 |
Methoxy poly(ethylene glycol)-b-poly(lactide)-Pyridine dithioethylamide endcap,甲氧基聚乙二醇聚乳酸巯基吡啶 |
231 |
h |
2024-04-03 |
| 176169 |
mPEG-PLA-OPSS,甲氧基聚乙二醇聚乳酸巯基吡啶 |
247 |
h |
2024-04-03 |
| 176170 |
CAS:1446261-44-4 Pamiparib 药物分子开发 |
230 |
zcy |
2024-04-03 |
| 176171 |
cas22112-84-1,5,10,15,20-四(4-氨基苯)-21H,23H-卟啉,分子量:674.794 |
281 |
axc |
2024-04-03 |
| 176172 |
CAS:2921-57-5 Methylprednisolone succinate 甲基泼尼松龙琥珀酸酯 线路优化 |
279 |
kx |
2024-04-03 |
| 176173 |
CAS:165800-03-3 Linezolid 利奈唑胺 批量生产 |
260 |
zcy |
2024-04-03 |
| 176174 |
cas186697-34-7,5,10,15,20-四[4-(2H-四唑-5-基)苯基] -21H,23H-卟吩,分子量:886.8858 |
270 |
axc |
2024-04-03 |
| 176175 |
CAS:74536-44-0 Metadoxine 美他多辛 工艺放大 |
294 |
kx |
2024-04-03 |